This is supported by cytogenetic and molecular findings: for example, CLL cells in such cases typically lack the Philadelphia chromosome or BCR::ABL1 fusion seen in CML, and conversely, the myelogenous cells do not carry CLL-specific immunophenotypic markers or immunoglobulin gene rearrangements. Here, BCR is linked to B-cell chronic lymphocytic leukemia.